| Name | ofatumumab | 
|---|
| Description | Ofatumumab (Arzerra) is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1]. | 
|---|---|
| Related Catalog | |
| References | [1]. Sanford M, McCormack PL. Ofatumumab. Drugs. 2010;70(8):1013-1019. | 
| No Any Chemical & Physical Properties |